Purchase Order HHSN302201500038PC

The U.S. civilian federal agency's Office of the Director awarded a Blanket Purchase Agreement (BPA) call valued at $5,762.72 to Domestic Awardees (Undisclosed) on October 31, 2012, for drugs and biologicals. This firm fixed-price contract, which was not subject to a set-aside designation, is scheduled for ultimate completion on June 30, 2013, with performance taking place in Hercules, California. The award represents a task order or call against an existing BPA vehicle, which provides an...

This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 21 (VISN 21), a civilian agency, to Biologics, Inc., a for-profit pharmaceutical company and subsidiary of McKesson Corporation. The contract is for the supply of the pharmaceutical drug LENALIDOMIDE, a medication used for the treatment of various types of cancer. The contract has a ceiling value of $29,628.21 and an ultimate completion date of December 14, 2025. The contract was competitively...

<p>This is a federal contract award from the U.S. Department of Health and Human Services (HHS) to Fleming and Company Pharmaceuticals, a pharmaceutical company. The contract is for the delivery of DRUGS AND BIOLOGICALS, with a ceiling value of $11,928,795.00. It is a firm fixed-price delivery order contract with a period of performance ending on March 16, 2010. The contract does not have a set-aside designation.</p>

This federal contract award is for the procurement of &quot;DRUGS AND BIOLOGICALS&quot; by the U.S. Federal agency, the Office of the Director. The $5,280.00 Firm Fixed Price contract was awarded on June 13, 2014 to Life Technologies Corporation, doing business as Thermo Fisher Scientific, a prominent manufacturer of scientific instruments, reagents, and consumables. The contract has an ultimate completion date of April 30, 2015 and is not set aside for any specific business type. Life...

This delivery order, valued at $44,179.34, awards Amerisourcebergen Drug Corp the supply of Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025, and represents a firm fixed-price procurement with no set-aside designation. The Defense Logistics Agency, under the Department of Defense, is the funding federal agency, and the place of...

This federal contract award was made by the Office of the Director to Life Technologies Corporation, doing business as Thermo Fisher Scientific, a prominent manufacturer of scientific instruments, reagents, and consumables. The $10,430.20 Firm Fixed Price contract is for the delivery of &quot;DRUGS AND BIOLOGICALS&quot; and was awarded on July 21, 2014, with an ultimate completion date of April 30, 2015. This contract was not set aside. Life Technologies Corporation, the prime contractor, is a...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Renflex IS 100 mg vials, a biosimilar medication used to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ulcerative colitis. This firm fixed-price delivery order, valued at $5,400.46, was awarded on December 15, 2025, with an ultimate completion date of December 16, 2025, and was competitively awarded without a set-aside designation. The work will be performed...

This federal contract award to Life Technologies Corporation, doing business as Thermo Fisher Scientific, is for the delivery of DRUGS AND BIOLOGICALS. The $4,800 Firm Fixed Price contract is a BPA Call, issued without a set-aside designation. The contract is funded by the Office of the Director, a civilian agency. The award is associated with two significant federal contract Indefinite Delivery Vehicles (IDVs) held by Life Technologies Corporation: a $3.5 million multi-award Blanket Purchase...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,330.52 to AmerisourceBergen Drug Corp for Adalimumab-aaty(cf) 80mg/0.8mls, a biosimilar immunosuppressant medication used to treat autoimmune conditions. This firm fixed-price, competitively awarded contract is scheduled for completion by December 22, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of VIVITROL 380 mg vial-diluents. This competitive award, utilizing firm fixed-price pricing, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The delivery order carries an ultimate completion date of...